CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 122 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $898,445 | +116.0% | 30,210 | +30.9% | 0.00% | – |
| Q2 2023 | $415,992 | -32.4% | 23,085 | -39.8% | 0.00% | – |
| Q1 2023 | $615,403 | +14.9% | 38,319 | +31.0% | 0.00% | – |
| Q4 2022 | $535,404 | +26.6% | 29,257 | +35.9% | 0.00% | – |
| Q3 2022 | $423,000 | -9.2% | 21,521 | -13.8% | 0.00% | – |
| Q2 2022 | $466,000 | -19.2% | 24,963 | -5.1% | 0.00% | – |
| Q1 2022 | $577,000 | -30.6% | 26,293 | -10.2% | 0.00% | – |
| Q4 2021 | $832,000 | -56.1% | 29,271 | -67.5% | 0.00% | -100.0% |
| Q3 2021 | $1,896,000 | +12.9% | 90,056 | +1.1% | 0.00% | 0.0% |
| Q2 2021 | $1,679,000 | +29.4% | 89,086 | +4.8% | 0.00% | 0.0% |
| Q1 2021 | $1,298,000 | +349.1% | 84,966 | +315.1% | 0.00% | – |
| Q4 2020 | $289,000 | +19.4% | 20,471 | +32.7% | 0.00% | – |
| Q3 2020 | $242,000 | -2.0% | 15,427 | +9.2% | 0.00% | – |
| Q2 2020 | $247,000 | +341.1% | 14,121 | +271.8% | 0.00% | – |
| Q1 2020 | $56,000 | -44.0% | 3,798 | -5.5% | 0.00% | – |
| Q4 2019 | $100,000 | +122.2% | 4,020 | +29.6% | 0.00% | – |
| Q3 2019 | $45,000 | -44.4% | 3,101 | -5.4% | 0.00% | – |
| Q2 2019 | $81,000 | -61.4% | 3,278 | -64.9% | 0.00% | – |
| Q1 2019 | $210,000 | +3.4% | 9,346 | +36.5% | 0.00% | – |
| Q4 2018 | $203,000 | -76.1% | 6,846 | -76.9% | 0.00% | – |
| Q3 2018 | $848,000 | – | 29,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |